medtronic inc (MDT:New York)

Executive Profile*

Background*

Mr. James T. Lenehan, Jim serves as an Advisor of Cerberus Capital Partners. Mr. Lenehan is a Private Investment Consultant. He has been a Consultant of Cerberus Capital Management since October 2004. He served as the President of Johnson & Johnson from April 2002 to February 1, 2004. Mr. Lenehan joined Johnson & Johnson in October 1976 and held several Marketing Management positions before becoming the President of McNeil Consumer Products Company in 1990. He began ... his career with Pepsico. He serves as the Chairman of Princeton Pharma Holdings LLC, the parent company of Aton Pharma Inc. Mr. Lenehan served as Worldwide Chairman of Consumer Pharmaceuticals & Professional Group since 1994 and the Worldwide Chairman of Medical Devices & Diagnostics Group since 1999. He served as a Vice Chairman of Johnson & Johnson from 2001 to February 1, 2004. Mr. Lenehan serves as a Director of Aton Pharmaceuticals Inc., Imthera Medical, Inc., and Talecris BioPharmaceuticals. He has been a Director of NovoCure Ltd., since January 2013. He has been a Director of Medtronic Inc., since January 18, 2007. Mr. Lenehan served as a Director of BlackLight Power Inc., since April 2009. He served as a Director of Talecris Biotherapeutics Holdings Corp., (Former Name: Talecris Biotherapeutics Inc) from April 2005 to June 1, 2011. He served as a Member of Advisory Board at Prescient Medical Inc. He served as a Director of Johnson & Johnson from 2001 to June 30, 2004. He serves as a Trustee of the Healthcare Leadership Council. Mr. Lenehan holds a BA in Economics from the University of Akron and an MBA from J.L. Kellogg School of Management, Northwestern University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
MDT:US	$49.84 USD	+0.20

COMPETITOR COMPENSATION